Hot Pursuit     19-Aug-22
Gland Pharma Ltd up for third consecutive session
Gland Pharma Ltd is quoting at Rs 2440.8, up 1.74% on the day as on 12:49 IST on the NSE. The stock is down 38.35% in last one year as compared to a 8.07% drop in NIFTY and a 6.38% drop in the Nifty Metal index.

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 2440.8, up 1.74% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 1% on the day, quoting at 17777.7. The Sensex is at 59677.43, down 1.03%. Gland Pharma Ltd has dropped around 1.32% in last one month.

Meanwhile, Nifty Metal index of which Gland Pharma Ltd is a constituent, has dropped around 0.99% in last one month and is currently quoting at 12935.75, down 0.76% on the day. The volume in the stock stood at 1.86 lakh shares today, compared to the daily average of 6.67 lakh shares in last one month.

The PE of the stock is 36.21 based on TTM earnings ending June 22.

Previous News
  Stock alert: Gland Pharma, Gujarat Fluorochem, Ujjivan SFB, Prestige Estates, IREDA
 ( Market Commentary - Stock Alert 24-Jun-24   08:41 )
  Gland Pharma consolidated net profit declines 72.48% in the March 2023 quarter
 ( Results - Announcements 19-May-23   07:25 )
  Gland Pharma Dundigal facility gets EIR from USFDA
 ( Hot Pursuit - 24-Aug-23   12:15 )
  Gland Pharma Ltd leads gainers in 'A' group
 ( Hot Pursuit - 08-Aug-23   12:00 )
  Indices hit record high; Sensex breaches 75K; broader mkt underperforms
 ( Market Commentary - Mid-Session 23-May-24   13:32 )
  Gland Pharma consolidated net profit declines 20.14% in the September 2022 quarter
 ( Results - Announcements 27-Oct-22   08:12 )
  Gland Pharma hits the roof after strong sequential performance
 ( Hot Pursuit - 08-Aug-23   10:47 )
  Gland Pharma tumbles after Q4 PAT declines over 72% YoY
 ( Hot Pursuit - 19-May-23   09:37 )
  Gland Pharma Ltd down for fifth straight session
 ( Hot Pursuit - 10-Nov-22   13:36 )
  Gland Pharma's Dundigal unit receives Establishment Inspection Report from USFDA
 ( Corporate News - 24-Aug-23   11:59 )
  Gland Pharma raises Rs 1,944 cr from anchor investors ahead of IPO
 ( IPO Centre - IPO News 07-Nov-20   17:29 )
Other Stories
  Shalby drops after PAT slides 20% YoY to Rs 16 cr in Q1 FY25
  08-Jul-24   16:01
  Tata Steel Production rises 5% YoY in Q1 FY24
  08-Jul-24   15:54
  PC Jeweller soars after PNB approves settlement
  08-Jul-24   15:26
  Godrej Inds gains after chemicals arm inks BTA to acquire Ethoxylation Unit II
  08-Jul-24   15:22
  GE Power sizzles after NTPC order win
  08-Jul-24   15:02
  Patel Engineering Ltd leads losers in 'A' group
  08-Jul-24   15:01
  Sundaram Multi Pap Ltd leads losers in 'B' group
  08-Jul-24   14:46
  Marine Electricals jumps after order win
  08-Jul-24   14:33
  Volumes soar at Metro Brands Ltd counter
  08-Jul-24   14:30
  Bank of India Q1 domestic deposits grow 10% YoY
  08-Jul-24   14:25
Back Top